ArticleLeukemia2024

Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cells.

Nicolas Chatain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.